Literature DB >> 11900461

In vitro development of growing oocytes from fetal mouse oocytes: stage-specific regulation by stem cell factor and granulosa cells.

Francesca Gioia Klinger1, Massimo De Felici.   

Abstract

The development of follicles in the mammalian ovary involves a bidirectional communication system between the follicular cells and oocyte that is now beginning to be characterized. Little is known about the mechanisms underlying the beginning of the oocyte growth and the acquisition of the competence to resume meiosis by the growing oocyte. In the present study, we devised a multistep culture system for mouse oocytes obtained from 15.5- to 16.5-days postcoitum embryos (mean diameter +/- SEM, 9.7 +/- 1.3 microm), allowing three stages of the oocyte growth to be identified: (i) an early stage in which the oocyte growth is induced by direct stimulation of a soluble growth factor, namely stem cell factor (SCF), independent of the formation of gap junctions with granulosa cells; (ii) a second phase in which the oocyte growth depends on the combined action of SCF and contacts with granulosa cells; and (iii) a third phase of granulosa cell-dependent, SCF-independent growth. At each stage, key events of oocyte development and differentiation, such as the c-kit reexpression, the early zona pellucida assembly, and the beginning of follicologenesis, were observed to occur independently by the presence of SCF. At the end of the in vitro growing phases, lasting 18-20 days, oocytes reached a size (50 +/- 2.5 microm) and a chromatin differentiation (stage I-II) equivalent to those of 9- to 10-day-old preantral oocytes and were unable to complete the growth phase. About 50% of the in vitro-grown oocytes were induced to resume meiosis by okadaic acid (OA) treatment. However, a significant fraction of them (48%) showed inability to maintain the chromosome condensation in M-phase. When in vitro-grown oocytes were treated with UO126, a specific MEK inhibitor that prevents activation of mitogen-activated protein kinases (ERK-1 and ERK-2), for 1 h before, during, and following OA treatment, only 22% of oocytes underwent germinal vesicle breakdown after 24 h from the OA treatment. These studies demonstrate that SCF alone can induce the onset of the oocyte growth. This is, however, not sufficient to fully activate the mechanisms governing the acquisition of the meiotic competence previously described as a 15-day oocyte-autonomous clock starting at the onset of growth. The inability of oocytes to progress into the last stages of growth and the lack of synchrony between nuclear and cytoplasm maturation showed by a subset of them resemble the characteristics of oocytes from connexin-37- and -43-deficient mice and indicate the preantral/antral transition point as a critical stage of oocyte development requiring the coordinated differentiation of the oocyte with granulosa cells and the maintenance of adequate communication between these two cell types to assure the correct oocyte meiotic maturation. Copyright 2002 Elsevier Science (USA).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11900461     DOI: 10.1006/dbio.2002.0592

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  25 in total

Review 1.  Bidirectional communication between oocytes and follicle cells: ensuring oocyte developmental competence.

Authors:  Gerald M Kidder; Barbara C Vanderhyden
Journal:  Can J Physiol Pharmacol       Date:  2010-04       Impact factor: 2.273

2.  Women with high telomerase activity in luteinised granulosa cells have a higher pregnancy rate during in vitro fertilisation treatment.

Authors:  Hong Chen; Wenjun Wang; Yaqin Mo; Yun Ma; Nengyong Ouyang; Ruiqi Li; Meiqi Mai; Yingming He; M M Abide Bodombossou-Djobo; Dongzi Yang
Journal:  J Assist Reprod Genet       Date:  2011-06-30       Impact factor: 3.412

3.  The Src homology 2 domain-containing adapter protein B (SHB) regulates mouse oocyte maturation.

Authors:  Gabriela Calounova; Gabriel Livera; Xiao-Qun Zhang; Kui Liu; Roger G Gosden; Michael Welsh
Journal:  PLoS One       Date:  2010-06-16       Impact factor: 3.240

4.  Developmental and ultrastructual characteristics of mouse oocytes grown in vitro from primordial germ cells.

Authors:  Hideyuki H Motohashi; Hidemi Kada; Kahei Sato
Journal:  Hum Cell       Date:  2004-03       Impact factor: 4.174

Review 5.  Instructing an embryonic stem cell-derived oocyte fate: lessons from endogenous oogenesis.

Authors:  Cory R Nicholas; Shawn L Chavez; Valerie L Baker; Renee A Reijo Pera
Journal:  Endocr Rev       Date:  2009-04-14       Impact factor: 19.871

6.  Transplantation directs oocyte maturation from embryonic stem cells and provides a therapeutic strategy for female infertility.

Authors:  Cory R Nicholas; Kelly M Haston; Amarjeet K Grewall; Teri A Longacre; Renee A Reijo Pera
Journal:  Hum Mol Genet       Date:  2009-08-20       Impact factor: 6.150

7.  In vitro growth of mouse preantral follicles: effect of animal age and stem cell factor/insulin-like growth factor supplementation.

Authors:  Byung Chul Jee; Jee Hyun Kim; Da Hyun Park; Hyewon Youm; Chang Suk Suh; Seok Hyun Kim
Journal:  Clin Exp Reprod Med       Date:  2012-09-30

8.  Growth of mouse oocytes to maturity from premeiotic germ cells in vitro.

Authors:  Zhi-Peng Zhang; Gui-Jin Liang; Xi-Feng Zhang; Guo-Liang Zhang; Hu-He Chao; Lan Li; Xiao-Feng Sun; Ling-Jiang Min; Qing-Jie Pan; Qing-Hua Shi; Qing-Yuan Sun; Massimo De Felici; Wei Shen
Journal:  PLoS One       Date:  2012-07-24       Impact factor: 3.240

9.  Spontaneous generation of germline characteristics in mouse fibrosarcoma cells.

Authors:  Zhan Ma; Yao Hu; Guoying Jiang; Jun Hou; Ruilai Liu; Yuan Lu; Chunfang Liu
Journal:  Sci Rep       Date:  2012-10-17       Impact factor: 4.379

10.  Spatial distribution and receptor specificity of zebrafish Kit system--evidence for a Kit-mediated bi-directional communication system in the preovulatory ovarian follicle.

Authors:  Kai Yao; Wei Ge
Journal:  PLoS One       Date:  2013-02-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.